Amendment #1490 to H5500

GLP-1 Equity Amendment

Mr. Turco of Winthrop moves to amend the bill by added at the end a new section:

Section XX

Chapter 32A of the General Laws is hereby amended by inserting after section 17Z the following section:-

Section 17AA. (a) The commission shall provide to any active or retired employee of the commonwealth who is insured under the group insurance commission reimbursement for glucagon-like peptide-1 (GLP-1) receptor agonist prescriptions that are fulfilled directly by the manufacturer; provided, that the medication was prescribed by a licensed physician. To obtain reimbursement under this section, the commission may require submission of proof of the prescription and proof of payment to the manufacturer.

(b) The commission may set a deductible for medications reimbursed pursuant to this section and such deductible shall be subtracted from the price paid to the manufacturer before reimbursement. The rate of reimbursement pursuant to this section shall not exceed the commission's average in-network pharmacy benefit rate.

Additional co-sponsor(s) added to Amendment #1490 to H5500

GLP-1 Equity Amendment